Chief Financial Officer
- Compensation
- SGD 10K–SGD 20K / mo
- Location
- Singapore
- Work setup
- Not specified
- Seniority
- C level
- Employment
- Not specified
- Experience
- 10+ years
- Category
- Finance
- Posted
Skills
Must have
- A demonstrated track record in raising capital or securing investment; preferably for biotechnology industry.
- A recognized degree in Finance, Accounting, Economics, Business Administration, or a related discipline.
- A professional accounting qualification such as CA Singapore, ACCA, CPA, or an equivalent qualification is advantageous.
- At least 10 years of relevant experience in finance, corporate finance, investment, or financial leadership, including substantial senior-level experience.
- Experience leading or materially contributing to completed fundraising rounds, private investments, venture capital transactions, strategic investments, or other corporate financing arrangements.
- Established relationships with biotechnology investors, venture capital firms or other relevant sources of capital.
- Strong commercial understanding of biotechnology business models, R&D investment, development milestones, intellectual property, licensing, strategic partnerships, and commercialization pathways.
- Excellent negotiation, analytical, communication, and stakeholder management skills.
- High standards of integrity, professionalism, accountability, and strategic judgement.
Full description
About the Role
We are seeking an experienced and commercially astute Chief Financial Officer (CFO) to lead our financial strategy, fundraising activities, capital management and corporate finance function.
This is a strategic leadership position requiring a proven track record in raising capital, securing investment and building relationships with investors and financial institutions. The successful candidate will play a central role in securing the financial resources required to advance the company's biotechnology programmes, achieve key development milestones, strengthen its intellectual property portfolio and support future commercialization.
Working closely with the CEO, Board of Directors, scientific leadership and business development team, the CFO will translate the company's scientific and business strategy into a compelling investment proposition and establish sustainable funding pathways for its next stages of growth.
Key Responsibilities1. Fundraising and Capital Raising
- Develop and execute a comprehensive fundraising and capital strategy aligned with the company's R&D pipeline, development milestones, operational requirements and long-term business objectives.
- Lead capital-raising initiatives, strategic corporate investment, private placements and other suitable financing arrangements.
- Identify, approach, and engage potential investors,
- Identify, engage, build and maintain a strong pipeline of potential investors and financing opportunities to support current and future funding rounds.
- Lead the preparation of investor presentations, financial models, business plans, fundraising proposals and investment materials.
- Manage the fundraising process from investor identification and initial engagement through due diligence, term sheet negotiation, transaction documentation and closing.
- Evaluate investment proposals, company valuations, equity dilution, liquidation preferences, investor rights, and other financing terms to protect the company's long-term interests.
- Advise the CEO and Board on funding strategy, capital structure, valuation, financing alternatives and the timing of fundraising rounds.
- Explore strategic partnerships and co-investment opportunities with biotechnology companies, pharmaceutical companies, research institutions, and other industry participants.
2. Biotechnology Financing and R&D Portfolio Management
- Develop financial plans and funding strategies that support research and clinical development activities.
- Work with scientific and programme leaders to develop milestone-based budgets, financial forecasts, and resource allocation plans.
- Evaluate the financial implications of R&D investments, intellectual property development, licensing opportunities, and external research collaborations.